Search research articles
Contact Us
Filters
Showing results (31-40 of 71) with videos related to
Page
of 8
Sort By:
Journal of Cutaneous Medicine and Surgery
|
September 1, 2020
The Incidence and Prevalence of Uveitis in Psoriasis: A Systematic Review and Meta-Analysis
Megan Lam, Jeremy Steen, Justin Di Lu, et al.
The Journal of Dermatological Treatment
|
October 10, 2024
A systematic review of recent randomized controlled trials for palmoplantar pustulosis
Miranda K Branyiczky, Shahnawaz Towheed, Tiago Torres, et al.
Applied Health Economics and Health Policy
|
August 11, 2012
Work productivity and healthcare resource utilization outcomes for patients on etanercept for moderate-to-severe plaque psoriasis: results from a 1-year, multicentre, open-label, single-arm study in a clinical setting
Ronald Vender, Charles Lynde, Vincent Ho, et al.
Journal of Cutaneous Medicine and Surgery
|
March 17, 2015
Non-melanoma Skin Cancer in Canada Chapter 2: Primary Prevention of Non-melanoma Skin Cancer
Kirk Barber, Gordon E Searles, Ronald Vender, et al.
Journal of the American Academy of Dermatology
|
March 25, 2014
Interleukin 17A: toward a new understanding of psoriasis pathogenesis
Charles W Lynde, Yves Poulin, Ronald Vender, et al.
European Journal of Dermatology : EJD
|
January 14, 2011
Quality of life in plaque psoriasis patients treated with voclosporin: a Canadian phase III, randomized, multicenter, double-blind, placebo-controlled study
Rod Kunynetz, Wayne Carey, Richard Thomas, et al.
Journal of Cutaneous Medicine and Surgery
|
April 16, 2013
One-year, multicenter, open-label, single-arm study evaluating the safety and effectiveness of etanercept for the treatment of moderate-to-severe plaque psoriasis in a Canadian population
Ronald Vender, Charles Lynde, Martin Gilbert, et al.
Journal of Cutaneous Medicine and Surgery
|
January 8, 2010
Efficacy outcomes in patients using alefacept in the AWARE study
Ian Landells, Gordon Searles, Robert Bissonnette, et al.
Cutis
|
April 15, 2009
Short-contact clobetasol propionate shampoo 0.05% improves quality of life in patients with scalp psoriasis
Jerry Tan, Richard Thomas, Béatrice Wang, et al.
Skin Therapy Letter
|
May 9, 2022
Halobetasol Propionate 0.01% Lotion for Plaque Psoriasis and Corticosteroid-Responsive Dermatoses
Abrahim Abduelmula, Brian D Rankin, Ronald Vender, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 71) with videos related to
Sort By:
Page
of 8
Journal of Cutaneous Medicine and Surgery
|
September 1, 2020
The Incidence and Prevalence of Uveitis in Psoriasis: A Systematic Review and Meta-Analysis
Megan Lam, Jeremy Steen, Justin Di Lu, et al.
The Journal of Dermatological Treatment
|
October 10, 2024
A systematic review of recent randomized controlled trials for palmoplantar pustulosis
Miranda K Branyiczky, Shahnawaz Towheed, Tiago Torres, et al.
Applied Health Economics and Health Policy
|
August 11, 2012
Work productivity and healthcare resource utilization outcomes for patients on etanercept for moderate-to-severe plaque psoriasis: results from a 1-year, multicentre, open-label, single-arm study in a clinical setting
Ronald Vender, Charles Lynde, Vincent Ho, et al.
Journal of Cutaneous Medicine and Surgery
|
March 17, 2015
Non-melanoma Skin Cancer in Canada Chapter 2: Primary Prevention of Non-melanoma Skin Cancer
Kirk Barber, Gordon E Searles, Ronald Vender, et al.
Journal of the American Academy of Dermatology
|
March 25, 2014
Interleukin 17A: toward a new understanding of psoriasis pathogenesis
Charles W Lynde, Yves Poulin, Ronald Vender, et al.
European Journal of Dermatology : EJD
|
January 14, 2011
Quality of life in plaque psoriasis patients treated with voclosporin: a Canadian phase III, randomized, multicenter, double-blind, placebo-controlled study
Rod Kunynetz, Wayne Carey, Richard Thomas, et al.
Journal of Cutaneous Medicine and Surgery
|
April 16, 2013
One-year, multicenter, open-label, single-arm study evaluating the safety and effectiveness of etanercept for the treatment of moderate-to-severe plaque psoriasis in a Canadian population
Ronald Vender, Charles Lynde, Martin Gilbert, et al.
Journal of Cutaneous Medicine and Surgery
|
January 8, 2010
Efficacy outcomes in patients using alefacept in the AWARE study
Ian Landells, Gordon Searles, Robert Bissonnette, et al.
Cutis
|
April 15, 2009
Short-contact clobetasol propionate shampoo 0.05% improves quality of life in patients with scalp psoriasis
Jerry Tan, Richard Thomas, Béatrice Wang, et al.
Skin Therapy Letter
|
May 9, 2022
Halobetasol Propionate 0.01% Lotion for Plaque Psoriasis and Corticosteroid-Responsive Dermatoses
Abrahim Abduelmula, Brian D Rankin, Ronald Vender, et al.
Page
of 8